drugset / Trial / NCT07350135

Sodium Supplementation and Growth in Premature Neonates

NCT07350135

Active not recruiting 74 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindSupportive care

Summary

Primary aim: to assess the impact of late (≥7 days postnatal) sodium supplementation of premature neonates with birth weight less than 2500 gm on their postnatal short-term catch-up growth. Secondary aim: to find out the effect of this sodium supplementation on fractional excretion of sodium, hemodynamics and prematurity-related short-term neonatal outcomes including morbidities and morality.

Timeline

Start
2025-11-06
Primary completion
2028-11-06
Completion
2028-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown 4 meq Intravenous

Indications

No indication recorded.